Literature DB >> 18337427

Widespread maculopapular rash due to intramuscular interferon beta-1a during the treatment of multiple sclerosis.

G Serarslan1, Ee Okuyucu, Im Melek, S Hakverdi, T Duman.   

Abstract

We describe a 41-year-old woman with multiple sclerosis, who presented erythematous maculopapular rash on the trunk and extremities after the second injection of interferon beta-1a. Histopathologic examination of the lesion revealed lymphocytic exocytosis and perivascular lymphocytic infiltrate in the dermis. Oral antihistamine and topical corticosteroid was started. After improvement of the lesions, the third injection was performed. However, the same reaction occurred. A prick test, which was performed 6 weeks after the eruption, also revealed positive reaction. Although injection-site reactions have been observed with interferon beta-1a, to our knowledge there have been no previous reports of interferon beta-1a-induced widespread cutaneous reaction.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18337427     DOI: 10.1177/1352458507079945

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  2 in total

Review 1.  Cutaneous Adverse Effects of Neurologic Medications.

Authors:  Eman Bahrani; Chloe E Nunneley; Sylvia Hsu; Joseph S Kass
Journal:  CNS Drugs       Date:  2016-03       Impact factor: 6.497

2.  Severe polymorphic erythema due to interferon α-2b during treatment of hairy cell leukemia.

Authors:  Chen Li; Hui Geng; Linhua Ji; Yan Jiang; Xiaojing Ma; Qichao Yin; Hua Xiong
Journal:  J Int Med Res       Date:  2019-06-27       Impact factor: 1.671

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.